Pay in 4 interest-free payments of $5.00 Learn more
Ships within 48 hours · Estimated delivery Sep 4 - Sep 9
1997 Oct;76(10):1398-404
Our physicians will discuss your complete health history during consultation
The hypolipidemic action of bezafibrate therapy in hypertriglyceridemia is mediated by upregulation of lipoprotein lipase: no effects on VLDL substrate affinity to lipolysis or LDL receptor binding
It is essential to follow the dosing instructions provided by your physician or pharmacist
By serving as a stable, bioactive ligand, the compound enables detailed mapping of binding affinities, receptor activation profiles, and subsequent intracellular events in various cell types
US$ 23.59
US$ 27.32
US$ 28.52
US$ 29.95
US$ 23.83
US$ 28.39
US$ 24.17
US$ 24.05
US$ 20.64
US$ 28.78
